Liver Failure Therapeutics Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report ID: 54443 | Published Date: Oct 2024 | No. of Page: 109 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL LIVER FAILURE THERAPEUTICS INDUSTRY
    2.1 Summary about Liver Failure Therapeutics Industry
    2.2 Liver Failure Therapeutics Market Trends
        2.2.1 Liver Failure Therapeutics Production & Consumption Trends
        2.2.2 Liver Failure Therapeutics Demand Structure Trends
    2.3 Liver Failure Therapeutics Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 Ornithine Phenylacetate
        4.2.2 MTL-CEBPA
        4.2.3 F-573
        4.2.4 BL-1220
        4.2.5 PP-100
        4.2.6 Others
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Clinic
        4.3.2 Hospital
        4.3.3 Others
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 Ornithine Phenylacetate
        5.2.2 MTL-CEBPA
        5.2.3 F-573
        5.2.4 BL-1220
        5.2.5 PP-100
        5.2.6 Others
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Clinic
        5.3.2 Hospital
        5.3.3 Others
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 Ornithine Phenylacetate
        6.2.2 MTL-CEBPA
        6.2.3 F-573
        6.2.4 BL-1220
        6.2.5 PP-100
        6.2.6 Others
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Clinic
        6.3.2 Hospital
        6.3.3 Others
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 Ornithine Phenylacetate
        7.2.2 MTL-CEBPA
        7.2.3 F-573
        7.2.4 BL-1220
        7.2.5 PP-100
        7.2.6 Others
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Clinic
        7.3.2 Hospital
        7.3.3 Others
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 Ornithine Phenylacetate
        8.2.2 MTL-CEBPA
        8.2.3 F-573
        8.2.4 BL-1220
        8.2.5 PP-100
        8.2.6 Others
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Clinic
        8.3.2 Hospital
        8.3.3 Others
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 Ornithine Phenylacetate
        9.2.2 MTL-CEBPA
        9.2.3 F-573
        9.2.4 BL-1220
        9.2.5 PP-100
        9.2.6 Others
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Clinic
        9.3.2 Hospital
        9.3.3 Others
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Alfact Innovation
        10.1.2 BioLineRx Ltd
        10.1.3 Cell2B Advanced Therapeutics SA
        10.1.4 Conatus Pharmaceuticals Inc
        10.1.5 Immune Pharmaceuticals Inc
        10.1.6 Mina Therapeutics Ltd
        10.1.7 Mylan NV
        10.1.8 Ocera Therapeutics Inc
        10.1.9 PledPharma AB
        10.1.10 Promethera Biosciences SA
        10.1.11 Silence Therapeutics Plc
        10.1.12 Unicyte AG
        10.1.13 Ventria Bioscience
        10.1.14 Vital Therapies Inc
    10.2  Liver Failure Therapeutics Sales Date of Major Players (2017-2020e)
        10.2.1 Alfact Innovation
        10.2.2 BioLineRx Ltd
        10.2.3 Cell2B Advanced Therapeutics SA
        10.2.4 Conatus Pharmaceuticals Inc
        10.2.5 Immune Pharmaceuticals Inc
        10.2.6 Mina Therapeutics Ltd
        10.2.7 Mylan NV
        10.2.8 Ocera Therapeutics Inc
        10.2.9 PledPharma AB
        10.2.10 Promethera Biosciences SA
        10.2.11 Silence Therapeutics Plc
        10.2.12 Unicyte AG
        10.2.13 Ventria Bioscience
        10.2.14 Vital Therapies Inc
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT
List of Table
Table Liver Failure Therapeutics Product Type Overview
Table Liver Failure Therapeutics Product Type Market Share List
Table Liver Failure Therapeutics Product Type of Major Players
Table Brief Introduction of Alfact Innovation
Table Brief Introduction of BioLineRx Ltd
Table Brief Introduction of Cell2B Advanced Therapeutics SA
Table Brief Introduction of Conatus Pharmaceuticals Inc
Table Brief Introduction of Immune Pharmaceuticals Inc
Table Brief Introduction of Mina Therapeutics Ltd
Table Brief Introduction of Mylan NV
Table Brief Introduction of Ocera Therapeutics Inc
Table Brief Introduction of PledPharma AB
Table Brief Introduction of Promethera Biosciences SA
Table Brief Introduction of Silence Therapeutics Plc
Table Brief Introduction of Unicyte AG
Table Brief Introduction of Ventria Bioscience
Table Brief Introduction of Vital Therapies Inc
Table Products & Services of Alfact Innovation
Table Products & Services of BioLineRx Ltd
Table Products & Services of Cell2B Advanced Therapeutics SA
Table Products & Services of Conatus Pharmaceuticals Inc
Table Products & Services of Immune Pharmaceuticals Inc
Table Products & Services of Mina Therapeutics Ltd
Table Products & Services of Mylan NV
Table Products & Services of Ocera Therapeutics Inc
Table Products & Services of PledPharma AB
Table Products & Services of Promethera Biosciences SA
Table Products & Services of Silence Therapeutics Plc
Table Products & Services of Unicyte AG
Table Products & Services of Ventria Bioscience
Table Products & Services of Vital Therapies Inc
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Liver Failure Therapeutics Market Forecast (Million USD) by Region 2021f-2026f
Table Global Liver Failure Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Liver Failure Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Liver Failure Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Liver Failure Therapeutics Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Liver Failure Therapeutics Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Liver Failure Therapeutics Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Liver Failure Therapeutics Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Liver Failure Therapeutics Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Liver Failure Therapeutics Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Liver Failure Therapeutics Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ornithine Phenylacetate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MTL-CEBPA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure F-573 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BL-1220 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PP-100 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ornithine Phenylacetate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MTL-CEBPA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure F-573 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BL-1220 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PP-100 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ornithine Phenylacetate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MTL-CEBPA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure F-573 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BL-1220 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PP-100 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ornithine Phenylacetate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MTL-CEBPA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure F-573 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BL-1220 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PP-100 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ornithine Phenylacetate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MTL-CEBPA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure F-573 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BL-1220 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PP-100 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ornithine Phenylacetate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MTL-CEBPA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure F-573 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BL-1220 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PP-100 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Alfact Innovation 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of BioLineRx Ltd 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Cell2B Advanced Therapeutics SA 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Conatus Pharmaceuticals Inc 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Immune Pharmaceuticals Inc 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Mina Therapeutics Ltd 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Mylan NV 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Ocera Therapeutics Inc 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of PledPharma AB 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Promethera Biosciences SA 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Silence Therapeutics Plc 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Unicyte AG 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Ventria Bioscience 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Vital Therapies Inc 2017-2020e
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Liver Failure Therapeutics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Liver Failure Therapeutics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Liver Failure Therapeutics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports